BT2 is a BCKDC kinase (BDK) inhibitor with an IC50 of 3.19 µM. BT2 binding to BDK triggers helix movements in the N-terminal domain, resulting in the dissociation of BDK from the branched-chain alpha-ketoacid dehydrogenase complex (BCKDC)[1]. BT2 (compound 4) is also a potent and selective Mcl-1 inhibitor with a Ki value of 59 µM[2].
Molekulargewicht:
247.10
Reinheit:
99.85
CAS Nummer:
[34576-94-8]
Formel:
C9H4Cl2O2S
Target-Kategorie:
Bcl-2 Family
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten